文献速递自身免疫性与大疱性皮肤病

天疱疮患者自评健康效用值:受控与未控寻常型及落叶型天疱疮

Patient-assigned health utility values for controlled and uncontrolled pemphigus vulgaris and foliaceus.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2019-07-26

该横断面问卷研究纳入108例天疱疮患者,采用复合时间权衡法(cTTO)评估当前健康及三种假设健康状态的效用值,并探索其决定因素。结果显示未控寻常型、未控落叶型及受控天疱疮的假设效用值分别为0.41、0.52和0.66,当前健康效用值为0.76;ABSIS评分更高、疼痛更重及有照护者的患者当前健康效用值更低。

要点

  • 未控寻常型、未控落叶型及受控天疱疮的假设健康效用值分别为0.41、0.52和0.66。
  • 患者当前健康效用均值为0.76,显著高于假设健康状态(P < 0.001)。
  • ABSIS评分更高、疼痛更重及有照护者与当前健康效用值降低相关(P < 0.05)。

核心结论

  • 天疱疮患者的健康相关生活质量损害以效用值表达较为显著,尤其与其他慢性皮肤病(如银屑病、特应性湿疹、慢性手部湿疹)相比。

研究设计与样本

  • 横断面问卷调查研究,纳入108例天疱疮患者(64.8%为女性,平均年龄57.4岁),疾病严重程度采用自身免疫性大疱性皮肤病强度评分(ABSIS)评估。
  • 患者通过复合时间权衡法(cTTO)评估当前健康及三种假设健康状态:未控寻常型天疱疮(PV)、未控落叶型天疱疮(PF)和受控PV/PF。
  • 采用多元回归分析探索效用值的决定因素。

主要发现

  • 假设未控PV、未控PF和受控PV/PF健康状态的cTTO平均效用值分别为0.41、0.52和0.66。
  • 当前健康的cTTO平均评分为0.76,高于假设健康状态(P < 0.001)。
  • ABSIS评分更高、疼痛强度评分更差及有照护者的患者当前健康效用值更低(P < 0.05)。
  • 患者平均ABSIS评分为11.6。

临床怎么用

  • 这些健康效用值有助于医生、政策制定者和资助方了解天疱疮健康损失的整体程度。
  • 为医疗决策及治疗策略的成本效果分析提供证据。

局限性

  • 未来需要研究评估天疱疮的照护者负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The assessment of health-related quality of life (HRQoL) in patients with pemphigus is now of increasing interest due to the availability of highly effective new therapies. Preference-based HRQoL values or health utilities required for medical and financial decision-making are not yet available directly from pemphigus patients. OBJECTIVE: To obtain health utility values for current health and hypothetical health states from the perspective of pemphigus patients. METHODS: A cross-sectional questionnaire survey was carried out with pemphigus patients. Disease severity was rated by Autoimmune Bullous Skin Disorder Intensity Score (ABSIS). Patients were asked to evaluate their current health as well as three common hypothetical pemphigus health states [uncontrolled pemphigus vulgaris (PV), uncontrolled pemphigus foliaceus (PF) and controlled PV/PF] by using composite time trade-off (cTTO). Multiple regression was applied to explore determinants of utility values. RESULTS: Responses of 108 patients (64.8% women, mean age 57.4 years) were analysed. Mean ABSIS score was 11.6. The mean utility values for the hypothetical uncontrolled PV, uncontrolled PF and controlled PV/PF health states were 0.41, 0.52 and 0.66 with cTTO. The mean cTTO scores for current health were higher compared with the hypothetical health states (0.76; P < 0.001). Patients with higher ABSIS, worse pain intensity scores and those having a caregiver reported lower utility values for current health (P < 0.05). CONCLUSIONS: In pemphigus, HRQoL impairment expressed in utility values seems to be considerable, especially in comparison with other chronic dermatological conditions (e.g. psoriasis, atopic eczema, chronic hand eczema). These health utilities inform physicians, policymakers and funders about the overall extent of health loss in pemphigus and provide evidence to guide medical decisions and cost-effectiveness analyses of treatment strategies. Future research is needed to evaluate the caregiver burden in pemphigus.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Hajdu K, Brodszky V, Stalmeier PFM, et al. Patient-assigned health utility values for controlled and uncontrolled pemphigus vulgaris and foliaceus. J Eur Acad Dermatol Venereol. 2019. PMID: 31265151. doi:10.1111/jdv.15765

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。